Gregory P. Hanson
2014 - MabVax Therapeutics Holdings
In 2014, Gregory P. Hanson earned a total compensation of $249.3K as Chief Financial Officer at MabVax Therapeutics Holdings.
Compensation breakdown
| Bonus | $10,000 |
|---|---|
| Option Awards | $56,331 |
| Salary | $180,269 |
| Other | $2,664 |
| Total | $249,264 |
Hanson received $180.3K in salary, accounting for 72% of the total pay in 2014.
Hanson also received $10K in bonus, $56.3K in option awards and $2.7K in other compensation.
Rankings
In 2014, Gregory P. Hanson's compensation ranked 12,089th out of 13,032 executives tracked by ExecPay. In other words, Hanson earned more than 7.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,089 out of 13,032 | 7th |
Division Manufacturing | 4,613 out of 4,965 | 7th |
Major group Chemicals And Allied Products | 1,577 out of 1,690 | 7th |
Industry group Drugs | 1,279 out of 1,369 | 7th |
Industry Pharmaceutical Preparations | 975 out of 1,042 | 6th |
Source: SEC filing on May 27, 2016.
Hanson's colleagues
We found four more compensation records of executives who worked with Gregory P. Hanson at MabVax Therapeutics Holdings in 2014.
2014
Michael Wick
MabVax Therapeutics Holdings
Chief Executive Officer
2014
J Hansen
MabVax Therapeutics Holdings
Chief Executive Officer
2014
Wolfgang Scholz
MabVax Therapeutics Holdings
Vice President, Antibody Discovery
2014
Paul Maffuid
MabVax Therapeutics Holdings